Abbott Laboratories
Bobbie acquires US infant-formula peer Nature’s One
Bobbie, the US infant-formula challenger business, has acquired peer Nature’s One for an undisclosed sum. San Francisco-based Bobbie, which describes…
FTC investigates baby-formula producers for collusion
The US Federal Trade Commission (FTC) is investigating whether baby-formula companies colluded on bids for profitable state contracts. FTC commissioner…
“We did ten months’ worth of inventory in the first two weeks after launch” – Bobbie co-founder Laura Modi on demand for the US start-up’s organic, “European-style” infant formula
Championed as the “only women-founded and mom-led infant-formula company in the US”, San Francisco challenger brand Bobbie was shaken soon…
Perrigo Co. infant formula recalled in North America in contamination scare
Ireland's Perrigo Company has seen some of its Gerber-branded infant-formula products recalled in North America after they were linked to…
Abbott Laboratories faces SEC, FTC investigation over infant formula shortage
US infant-formula manufacturer Abbott Laboratories is facing investigations by the Securities and Exchange Commission (SEC) and the Federal Trade Commission…
Reckitt recalls infant-formula in US in Cronobacter bacteria scare
Reckitt Benckiser has instigated a large-scale infant-formula recall in the US because of possible health risks linked to contamination from…
FDA to instigate changes in wake of criticism over infant-formula crisis
The Food and Drug Administration (FDA) is to overhaul the US regulator's structure and food-safety procedures in the wake of…
FDA food-safety chief quits amid news of DOJ criminal probe into Abbott
Frank Yiannas, a senior official at US regulator the Food and Drug Administration (FDA), has resigned his post in a…
Abbott Laboratories ‘facing DOJ probe into infant-formula crisis’
US baby-formula heavyweight Abbott Laboratories is reportedly facing a criminal investigation over an outbreak of salmonella at its Michigan plant…
US infant-formula imports ‘to face tariffs again’
Foreign providers that came to the rescue when the US faced an infant-formula shortage last year are likely to face…